Difference between revisions of "GPRC5D-AS1"
Jiabao Cao (talk | contribs) |
|||
(One intermediate revision by one other user not shown) | |||
Line 6: | Line 6: | ||
''RP11-392P7.6''<ref name="ref1" /> | ''RP11-392P7.6''<ref name="ref1" /> | ||
+ | ===Function=== | ||
+ | Mutations of ''RP11-392P7.6'' may contribute to the susceptibility to colorectal cancer and be a candidate biomarker for colorectal cancer risk prediction <ref name="ref1" />. | ||
===Disease=== | ===Disease=== | ||
*Colorectal cancer<ref name="ref1" /> | *Colorectal cancer<ref name="ref1" /> | ||
+ | |||
+ | ==Labs working on this lncRNA== | ||
+ | *Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health, Hangzhou, 310058, Zhejiang, China | ||
+ | *Institute for Cancer Prevention of Jiashan County, Zhejiang, China | ||
+ | |||
+ | ==References== | ||
+ | <references> | ||
+ | <ref name="ref1"> | ||
+ | Jin M, Gu S, Ye D, Li Y, Jing F, Li Q, Chen K. Association between genetic variants in the promoter region of a novel antisense long noncoding RNA RP11-392P7.6 and colorectal cancer risk. Environ Mol Mutagen. 2017 Jun 14. | ||
+ | </ref> | ||
+ | </references> |
Latest revision as of 03:00, 26 July 2017
RP11-392P7.6 is antisense to the coding region of cancer-related gene GPRC5D, which has been found recently.[1]
Contents
Annotated Information
Name
GPRC5D-AS1:GPRC5D and HEBP1 antisense RNA 1
RP11-392P7.6[1]
Function
Mutations of RP11-392P7.6 may contribute to the susceptibility to colorectal cancer and be a candidate biomarker for colorectal cancer risk prediction [1].
Disease
- Colorectal cancer[1]
Labs working on this lncRNA
- Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health, Hangzhou, 310058, Zhejiang, China
- Institute for Cancer Prevention of Jiashan County, Zhejiang, China